Correction: cdkl3 promotes osteosarcoma progression by activating akt/pkb

HIGHLIGHTS

• who: from the Correction: , promotes osteosarcoma progression by activating Akt/PKB Aina He1, *, Lanjing Ma3, *, Yujing Huang1, *, Haijiao Zhang3, Wei Duan4, Zexu Li3, Teng Fei3, Junqing Yuan5, Hao Wu6, Liguo Liu7, Yueqing Bai5, Wentao Dai8, Yonggang Wang1, Hongtao Li1, Yong Sun1, Yaling Wang1, Chunyan Wang1, Ting Yuan9, Qingcheng Yang9, Songhai Tian2, Min Dong2, Ren Sheng3, Dongxi Xiang10, , Department of Oncology, Shanghai Jiaotong University Affiliated Sixth People`s Hospital, Shanghai, PR China Department of Urology, Boston Children`s Hospital, Harvard Medical School, Boston, MA, USA College of Life and Health Sciences, Northeastern University, Shenyang, PR China School of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.